Biotech firm Windtree Therapeutics plans to purchase up to $700 million worth of BNB, the fifth-largest digital currency, following the asset's recent all-time high. The company, traded on Nasdaq as WINT, aims to secure $520 million specifically for BNB acquisitions, drawing from a $500 million equity line of credit and a $20 million stock purchase pact. Windtree has partnered with Kraken for custody and management of its crypto treasury strategy. The CEO emphasized the importance of gaining additional funds for buying more BNB to implement their strategy. BNB, launched in 2017 by Binance, boasts a market cap of $106.9 billion and recently traded around $769 after peaking at $808. Windtree is part of a broader trend where publicly traded companies are accumulating cryptocurrencies, enhancing their market valuations, a movement seen with firms like Strategy and Nano Labs.

Source đź”—